Conmed Corp (CNMD) Misses Q2 EPS by 2c; Lowers FY12 Sales Outlook; Guides Q3

July 26, 2012 7:57 AM

Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.43, $0.02 worse than the analyst estimate of $0.45. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found